Interferon beta-1a Completed Phase 3 Trials for Relapsing Multiple Sclerosis (RMS) Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care3
clinicaltrials.gov IdentifierTitleDrugs
NCT00619307Transition to Rebif New Formulation
NCT00472797Rebif New Formulation (RNF) Quality of Life (QOL) Study